Abstract
Platelet hyperaggregability was tested in 62 TIA patients by means of the formalin fixing principle of Wu and Hoak. Compared to age-matched controls, the platelet aggregates ratio (PAR) was reduced from 0.99±0.04 SD to 0.807±0.14 SD. This means a highly significant increase of circulating platelet aggregates (CPA) in untreated TIA patients, regardless of the interval sinche the last attack (from 2 days to 1 year). PAR was especially reduced in patients with abnormal angiography (expressing pronounced cerebral or diffuse ATS) and it was possibly affected by previous antiplatelet treatment with ASA.
Sommario
L'iperaggregabilità piastrinica è stata valutata in 62 pazienti affetti TIA mediante il metodo di Wu ed Hoak.
Il confronto con controlli di pari età ha evidenziato un significativo aumento degli aggregati piastrinici circolanti indipendentemente all'epoca dell'ultimo attacco.
I valori di PAR (paltelet aggregates ratio) sono risultati più ridotti nei pazienti con quadri angiografici patologici e più elevati nei malati con precedente terapia con ASA.
Similar content being viewed by others
References
Agnoli A., Fazio C.:Platelet Aggregation in the Pathogeneses of Cerebrovascular Disorders. Springer-Verlarg Berlin Heidelberg, New York, 1977.
Bansal B.C., Prakash C., Arya R.K., Gulali S.K., Mittal S.C.:Serum Lipids, Platelet and Fibrionolytic Activity in Cerebrovascular Disease. Stroke 9, 137–139, 1978.
Baumgartner H.R., Muggli R., Tschopp T.B., Turitto V.T.:Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thrombos. Haemostas. 35, 124–138, 1976.
Danta G.:Platelet Aggregation in Patients with Cerebral Vascular Disease and in Control Subjects. Thrombos. Diathes. Haemorrh. 29, 730–732, 1973.
De Marinis M., Falchetti R., Lorenzetti A., Prencipe M.:Quantificazione degli aggregati piastrinici circolanti: ripetibilità del metodo. Società Italiana di Biologia Sperimentale XLVIII Assemblea Generale. L'Aquila 27–29 September, 1979.
Dougherty J.H., Levy D.E., Weksler B.B.:Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebral vascular disease. Lancet 1, 821–824, 1977.
Fields W.S., Lemak N.A., Frankowski R.F., Hhardy R.J.:Controlled Trial of Aspirin in Cerebral Ischemia. Stroke 8, 301–316, 1977.
Fisher C.M.:Observation of Fundus Oculi in Transient Monocular Blindness. Neurology 9, 333–347, 1959.
Gunning A.J., Pickering G.W., Robb-Smith A.H.T., Ross Russel R.W.:Mural thrombosis of the internal carotid artery and subsequent embolism. Quart. J. Med. 33, 155–194, 1964.
Hossmann K.A., Hossmann V.:Coagulopathy following experimental cerebral ischemia. Stroke 8, 249–257, 1977.
Yamazaki H., Takahashi T., Tadahiro S.:Hyperaggregability of platelets in thromboembolic disorders. Thrombos. Diathes. Haemorrh. 34, 94–105, 1975.
Yon J.L., Anuras S., Wu K.K., andForker E.L.:Granulomatous hepatitis, increased platelet aggregation and hypercholesterolemia. Ann. Intern. Med. 84, 148–150, 1976.
Lenzi G.L., Laghi Pasini F., Vittoria A.:Observations on Platelet Aggregability in the acute phase of untreated strokes. InAgnoli A., Fazio C. (Eds.)Platelet aggregation in the pathogenesis of cerebrovascular disorders. Springer-Verlarg Berlin Heidelberg, New York, pp. 93–95, 1977.
Lowe G.D.O., Reavey M.M., Johnston R.V., Forbes C.D., Prentice C.R.M.:Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrod. Thrombos. Res., 14, 377–386, 1979.
Maca R.D., Fry G.L., Hoak J.C.:New Method for Detection and Quantitation of Circulating Platelet Aggregates. Microvase. Res. 4, 453–457, 1972.
Mannucci P.M., D'Angelo A., Vigano S., Mari D., Vanasia S., Passetti C., Pareti F.:Sindrome Trombofilica delle Vasculopatie Cerebrali. In Neri Serneri G.G. el al. (eds.) Aterosclerosi e stati trombofilici. 80o Congresso Società Italiana Medicina Interna Palermo 10 October, 1979. Pozzi Roma pp. 525–534, 1979.
Marshall J.:The Management of Cerebrovascular Disease. Blackwell Scientific Pubblication. Oxford-London Edimburgh Melburne, 1974.
Mehta J., Mehta P., Bueger C., Pepine C.J.:Platelet aggregation studies in coronary artery disease. Atherosclerosis 31, 169–175, 1978.
Mustard J.F., Kinlough-Rathbone R.L., Packham M.A.:Recent Status of Research in the Pathogenesis of Thrombosis. Thrombos. Diathes. Haemorrh. Suppl. 59, 157, 1974.
Nachman R.L.:The Platelet as an Inflammatory Cell. InAgnoli A., Fazio C. (eds.).Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders. Springer-Verlarg Berlin Heidelberg, New York, pp. 4–7, 1977.
Nyman D., Kjellin K.G., Mettinger K.L., Siden A., Söderström C.E.:Platelet dysfunction and fibrinolytic insufficiency — potential risk factors in ischaemic cerebrovascular disease. Acta Neurologica Scandinavica Suppl 67 Vol. 57, 252, 1978.
Packam M.A.:Methods for Detection of Hypersensitive Platelets. Philadelphia, June 1977. Thromb. Haemostas 40, 175–195, 1978.
Prazich J.A., Rapaport S.I., Samples J.R., Engler R.:Platelet Aggregate Ratios. Standardization of technique and test results in patients with myocardial ischaemia and patients with cerebrovascular disease. Thrombos. Haemostas 38, 597–605, 1977.
Prencipe M., Pissarri F.M., Agnoli A.:Platelet aggregation in cerebrovascular Patients. InAgnoli A., Fazio C. (eds.)Platelet aggragation in the pathogenesis of cerebrovascular disorders. Springer-Verlang Berlin, Heidelberg, New York. pp. 129–133, 1977.
Preston F.E., Ward J.D., Marcola B.H., Porter N.R., Timperley W.R., O'Malley B.C.:Elevated B-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1, 238–240, 1978.
Ross Russel R.W.:Obsevations on the retinal blood vessels in monocular blindness. Lancet 2, 1422–1428, 1961.
Sharma S.C., Vijayan G.P., Seth H.N., Suri M.L.:Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in young patients with ischaemic stroke. J. Neurol. Neurosurg. Phychiatr. 41, 118–121, 1978.
Sherry S.:The role of Platelet in Thrombosis. InCaprino L., Rossi E.C. (eds.)Platelet Aggregation and Drugs. Academic Press, New York, pp. 111–114, 1974.
Stirling Meyer J.:Summary of the Intermational Round Table Conference on Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders. Stroke 6, 239–244, 1975.
The Canadian Cooperative Study Group:A Randomized Trial of Aspirin and Sulfinpyrazone in threatened stroke. N. Engl. J. Med. 299, 53–59, 1978.
Walsh P'N., Kansu T., Savino P.J.:Platelet activities in arterial occlusive disease of the eye. Stoke 10, 589–594, 1979.
White A.M., Heptinstall S.:Contribution of platelets to thrombus formation. Br. Med. Bull. 34, 123–128, 1979.
Wu K.K., Hoak J.C.:A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2, 924–926, 1974.
Wu K.K., Hoak J.C.:Increased Platelet Aggregates in patients with Transient Ischemic Attacks. Stroke 6, 521–524, 1975.
Wu K.K.:Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann. Intern. Med. 88, 7–11, 1978.
Wu K.K.:Hyperactive platelets in thrombotic cerebro-vascular diseases: indication for anti-Platelet therapy. Simposio Internazionale Istituto M. Negri: Prevenzione e Trattamento Farmacologico delle CVP croniche, Milan 2–4, May, 1979.
Author information
Authors and Affiliations
Additional information
Supported by the National Research Council, Special Project on Preventive Medicine.
Rights and permissions
About this article
Cite this article
De Marinis, M., Fieschi, C., Prencipe, M. et al. Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks. Ital J Neuro Sci 1, 163–169 (1979). https://doi.org/10.1007/BF02335846
Issue Date:
DOI: https://doi.org/10.1007/BF02335846